Revotek Deploys Its Bioink Technology to Research Institutes apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Eosinophils modify the respiratory barrier during influenza A infection, shows study
For the first time in published literature, Le Bonheur Children s Hospital and University of Tennessee Health Science Center (UTHSC) researchers showed that a variety of white blood cells known as eosinophils modify the respiratory barrier during influenza A (IAV) infection, according to a recent paper in the journal
Cells.
This research could have implications in understanding SARS-CoV-2 (COVID-19) infection in asthmatic patients.
The Le Bonheur/UTHSC study found that eosinophils immunomodulate airway epithelial cells during IAV infection, helping to neutralize the virus and protect the airway.
The study was led by University of Tennessee Health Science Center Postdoctoral Fellow Meenakshi Tiwary, PhD, from the lab of Director of the Pediatric Asthma Research Program and Plough Foundation Chair of Excellence in Pediatrics, Amali Samarasinghe, PhD, in collaboration with Robert Rooney, PhD, assi
Adobe
In what some are calling a “persistent failure” of medical schools to improve diversity, a comprehensive new analysis going back 40 years shows the number of students from the most underrepresented groups in medicine Black males and Native American and Alaskan Native men and women has declined.
While Black male medical students accounted for 3.1% of the national medical student body in 1978, in 2019 they accounted for just 2.9%. Without the contribution of historically Black medical schools, just 2.4% would be Black men. The number of Native American students also declined, accounting for just a fraction of 1% of the nation’s roughly 22,000 medical students in 2019.
Antiviral response: Eosinophils active in immediate defense during influenza a infection eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
email article
Ready-to-use dasiglucagon (Zegalogue) an aqueous formula of a glucagon analogue reversed hypoglycemia for patients with type 1 diabetes in a median of 10 minutes, while plasma glucose recovery was achieved within 15 minutes for 99% of patients, according to phase III trial results. (
Diabetes Care)
Within the first few months of starting gender-affirming hormone therapy, mean systolic blood pressure was lower by 4 mm Hg for transfeminine individuals and higher by 2.6 mm Hg for transmasculine individuals. (
Hypertension)
Novo Nordisk is slated to test its oral semaglutide, approved for diabetes under the trade name Rybelsus, for obesity in a phase III trial after great success with once-weekly injectable semaglutide, which is marketed for diabetes under the name Ozempic. (